monoaminergic neurotransmission history discovery antidepressants num today pubmed ncbi abstract num clinical introduction specifically antidepressant drugs iproniazid monoamine-oxidase inhibitor treatment tuberculosis imipramine drug tricyclic antidepressant family iproniazid imipramine made fundamental contributions development psychiatry social-health nature consisting authentic change psychiatric care depressive patients purely pharmacological nature agents constituted indispensable research tool neurobiology psychopharmacology permitting things postulation aetiopathogenic hypotheses depressive disorders clinical introduction fluoxetine selective serotonin reuptake inhibitor late num revolutionized therapy depression opening families antidepressants present work reviews historical perspective entire process led discovery drugs contribution development neuroscientific disciplines antidepressants rest clinical practice share action mechanism involves modulation monoaminergic neurotransmission synaptic level future antidepressant therapy revolve search extraneuronal non-aminergic mechanisms mechanisms modulate intraneuronal biochemical pathways 
